Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from William Blair

Can Oklo Stock Hit $75 in 2025?

Wedbush analysts have an ambitious price target of $75 on Oklo’s stock.

Barchart · Jun 26, 2025

From In-N-Out to McDonald’s: The restaurant chains with the highest and lowest employee satisfaction scores revealed

91 percent of In-N-Out employees said they’d recommend their jobs to a friend

The Independent UK · Jun 11, 2025

Elon Musk’s ‘KILL the BILL’ Sends Tesla Shares Down. Is It Time to Sell TSLA Stock Here?

Tesla shares crater as President Donald Trump says he’s disappointed in Elon Musk. A William Blair analyst remains bullish on TSLA stock.

Barchart · Jun 5, 2025

From analysis to the latest developments in health,
read the most diverse news in one place.

Analysts Are Pounding the Table on This ‘Pioneer’ Nuclear Energy Stock

This nuclear stock has received a positive analyst rating after a favorable announcement from the government.

Barchart · Jun 3, 2025

This Analyst Is Calling for ‘Near Term’ Upside in Palantir Stock Despite the Tariffs Selloff

A William Blair analyst says Palantir stock is positioned for near-term gains. Should you buy the recent dip in PLTR shares then?

Barchart · Apr 7, 2025

The Bloodshed in Palantir Stock Is So Bad This Analyst Just Upgraded the Stock

A continued rout in Palantir stock made one of its long-time skeptics change his stance on the big data analytics firm on Wednesday.

Barchart · Mar 5, 2025

3 Tech Stocks to Buy for Steady Growth in 2025

These companies all have huge growth potential in 2025 thanks to innovation and transformation in industries like data centers and artificial intelligence.

Barchart · Dec 26, 2024

Read news from The Economist, FT, and more,
with one subscription

Regulatory Setback For Applied Therapeutics' Lead Program, FDA Highlights Deficiencies In Clinical Application

FDA rejected Applied Therapeutics' Govorestat for galactosemia, citing NDA deficiencies. The company plans discussions for resubmission or appeal.

Benzinga · Nov 29, 2024

Chipotle's new CEO gets approving nod from analysts

Boatwright is likely to look to new CFO Adam Rymer as a strategic partner.

Fortune · Nov 12, 2024

Viking Therapeutics Stock Swings Wildly After Weight-Loss Drug Data

Viking Therapeutics stock is volatile Monday after the pharma company released positive data for its weight-loss drug. Here's what you need to know.

Kiplinger · Nov 4, 2024

1 AI Growth Stock to Grab While It's Under $100

This AI stock is currently trading below $100 following a pullback, which could be a perfect window for investors to snag this growth stock now.

Barchart · Oct 20, 2024

Moderna Stock Plunges as Vaccine Maker Slashes R&D Budget: What to Know

Moderna stock is plunging Thursday after the COVID-19 vaccine maker announced plans to drastically cut its R&D spending to focus on new product approvals.

Kiplinger · Sep 12, 2024

Is Tesla Stock a Buy for Energy Storage Upside?

This article explores whether Tesla stock is a good investment for those looking to capitalize on the potential growth of its energy storage business, which is increasingly seen as a significant driver of future upside.

Barchart · Sep 5, 2024

Chewy Stock Soars on Big Profit Beat. Is It Time to Buy?

Chewy is red-hot Wednesday after the pet products retailer posted impressive Q2 earnings. Here's what Wall Street has to say about the stock.

Kiplinger · Aug 28, 2024

Get all your
news in one place.

100's of premium titles.
One news app.

Kiplinger · Jul 24, 2024

Visa Is the Worst Dow Stock Wednesday. Here's Why

Visa stock is down sharply Wednesday after the credit card company came up short of revenue expectations for its fiscal Q3.

Kiplinger · Jun 13, 2024

Dave & Buster's Stock Tanks on Earnings Miss: What To Know

Dave & Buster's stock is plunging after the entertainment and restaurant chain reported weaker-than-expected Q1 earnings. Here's what you need to know.

Barchart · Apr 15, 2024

1 Breakout Small-Cap Agricultural Stock to Scoop Up Now

With a growing population fueling demand for agricultural goods, it might be smart to consider investing in the small-cap agricultural stock Vital Farms now.

Barchart · Mar 20, 2024

Up 931% in One Year, Is Carvana Stock Overvalued?

Investor interest in Carvana stock continued to grow after the company reported its first-ever annual profit, leading to a 931% price spike over the past year. Is a pullback ahead for the stock?

Get all your
news in one place.

100's of premium titles.
One news app.

Zenger · Nov 3, 2023

PayPal Q3 Is ‘All About’ New CEO’s Vision: 5 Analysts Explore Earnings, Prospects

Shares of PayPal Holdings Inc (NASDAQ: PYPL) rose in early trading on Thursday, after the company reported its third-quarter (Q3) results

Fortune · Nov 1, 2023

The crime epidemic in places like San Francisco causing stores to flee could actually just be bad management, investment bank suggests

While crime has risen slightly, the numbers don’t match up, William James said in a research note, citing “potentially ulterior, more opportunistic motives.”

Zenger · Aug 2, 2023

Is Starbucks Too Dependent On China? 5 Analyst Takeaways On Mixed Q3 Print, Outlook

Shares of Starbucks Corp rose in early trading on Wednesday, after the company reported mixed fiscal third-quarter (Q3) results

Benzinga · Aug 11, 2022

Benzinga's Top Ratings Upgrades, Downgrades For August 11, 2022

Benzinga · May 3, 2022

Benzinga's Top Ratings Upgrades, Downgrades For May 3, 2022

Upgrades

Benzinga · Mar 28, 2022

Exane BNP Paribas Downgrades Trex To Underperform

Trex Company Inc (NYSE:TREX) has been downgraded to Underperform from Neutral, with a price target of $81 (an upside of 16%) by Exane BNP Paribas analyst Yves Bromehead. Meanwhile, William Blair analyst Ryan Merkel remains a buyer of TREX shares following his meeting with the company's management. Merkel lists several factors, including healthy demand, full contractor backlogs,…

Benzinga · Mar 16, 2022

Read Why William Blair Is Optimistic On This Car Wash Company

William Blair analyst Ryan Sundby initiated coverage of Mister Car Wash Inc (NYSE:MCW) with an Outperform rating and no price target. Sundby notes Mister Car Wash has become a leader in the U.S. car wash market. The investor specifies that the car wash industry can grow at a mid-single-digit rate. The analyst predicts a significant…

1 2 3

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.